$9.96
1.58% today
Nasdaq, Nov 26, 04:50 pm CET
ISIN
US00653Q1022
Symbol
AHCO

AdaptHealth Corp - Ordinary Shares - Class A Target price 2024 - Analyst rating & recommendation

AdaptHealth Corp - Ordinary Shares - Class A Classifications & Recommendation:

Buy
67%
Hold
33%

AdaptHealth Corp - Ordinary Shares - Class A Price Target

Target Price $11.39
Price $10.12
Potential
Number of Estimates 9
9 Analysts have issued a price target AdaptHealth Corp - Ordinary Shares - Class A 2025 . The average AdaptHealth Corp - Ordinary Shares - Class A target price is $11.39. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 9 analysts: 6 Analysts recommend AdaptHealth Corp - Ordinary Shares - Class A to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the AdaptHealth Corp - Ordinary Shares - Class A stock has an average upside potential 2025 of . Most analysts recommend the AdaptHealth Corp - Ordinary Shares - Class A stock at Purchase.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion $ 3.20 3.23
7.73% 1.04%
EBITDA Margin 20.66% 20.52%
1.01% 0.66%
Net Margin -20.81% 2.43%
1,039.40% 111.68%

9 Analysts have issued a sales forecast AdaptHealth Corp - Ordinary Shares - Class A 2024 . The average AdaptHealth Corp - Ordinary Shares - Class A sales estimate is

$3.2b
Unlock
. This is
0.89% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$3.2b 0.63%
Unlock
, the lowest is
$3.2b 1.23%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $3.2b 7.73%
2024
$3.2b 1.04%
Unlock
2025
$3.3b 2.90%
Unlock
2026
$3.5b 5.58%
Unlock

9 Analysts have issued an AdaptHealth Corp - Ordinary Shares - Class A EBITDA forecast 2024. The average AdaptHealth Corp - Ordinary Shares - Class A EBITDA estimate is

$664m
Unlock
. This is
4.87% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$668m 4.24%
Unlock
, the lowest is
$656m 5.96%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $661m 6.64%
2024
$664m 0.38%
Unlock
2025
$683m 2.95%
Unlock
2026
$723m 5.79%
Unlock

EBITDA Margin

2023 20.66% 1.01%
2024
20.52% 0.66%
Unlock
2025
20.53% 0.05%
Unlock
2026
20.57% 0.19%
Unlock

6 AdaptHealth Corp - Ordinary Shares - Class A Analysts have issued a net profit forecast 2024. The average AdaptHealth Corp - Ordinary Shares - Class A net profit estimate is

$78.6m
Unlock
. This is
136.18% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$125m 157.59%
Unlock
, the lowest is
$60.5m 127.88%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-666m 1,112.00%
2024
$78.6m 111.80%
Unlock
2025
$118m 50.74%
Unlock
2026
$153m 29.15%
Unlock

Net Margin

2023 -20.81% 1,039.40%
2024
2.43% 111.68%
Unlock
2025
3.56% 46.50%
Unlock
2026
4.35% 22.19%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -5.06 0.60
1,112.00% 111.86%
P/E 16.95
EV/Sales 1.07

6 Analysts have issued a AdaptHealth Corp - Ordinary Shares - Class A forecast for earnings per share. The average AdaptHealth Corp - Ordinary Shares - Class A <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$0.60
Unlock
. This is
136.36% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$0.95 157.58%
Unlock
, the lowest is
$0.46 127.88%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-5.06 1,112.00%
2024
$0.60 111.86%
Unlock
2025
$0.90 50.00%
Unlock
2026
$1.16 28.89%
Unlock

P/E ratio

Current -6.15 139.30%
2024
16.95 375.61%
Unlock
2025
11.24 33.69%
Unlock
2026
8.71 22.51%
Unlock

Based on analysts' sales estimates for 2024, the AdaptHealth Corp - Ordinary Shares - Class A stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.06 3.64%
2024
1.07 0.60%
Unlock
2025
1.04 2.82%
Unlock
2026
0.98 5.29%
Unlock

P/S ratio

Current 0.42 10.98%
2024
0.42 0.89%
Unlock
2025
0.41 2.83%
Unlock
2026
0.39 5.28%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today